drugset / Trial / NCT01231828

Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.

NCT01231828

Completed 55 enrolled University Hospital, Caen
RandomizedCrossoverQuadruple-blindPrevention

Summary

The project will improve scientific knowledge regarding a recent law applying potentially to every french driver. It will give for the first time an indication on the impact of alerting treatments on driving risks. It will reinforce the links between different research environments (sleep physiopathology, clinical research, cognitive neurosciences, drivers supervision, virtual reality, pharmacology) among the "Réseau Eveil Sommeil Attention et Transports" (RESAT) network.

Timeline

Start
2009-09
Primary completion
2012-06
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 4 g
Subject Lactulose Other / unclassified 30 ml
Subject Lactulose Other / unclassified 60 ml

Indications